Background: Bone injury is common in many clinical situations, such as surgery or trauma. During surgery, excessive reactive oxygen species (ROS) production decreases the quality and quantity of osteoblasts. Remifentanil decreases ROS production, reducing oxidative stress and the inflammatory response. We investigated remifentanil's protective effects against H2O2-induced oxidative stress in osteoblasts. Methods: To investigate the effect of remifentanil on human fetal osteoblast (hFOB) cells, the cells were incubated with 1 ng/ml of remifentanil for 2 h before exposure to H2O2. For induction of oxidative stress, hFOB cells were then treated with 200 μM H2O2 for 2 h. To evaluate the effect on autophagy, a separate group of cells were incubated with 1 mM 3-methyladenine (3-MA) before treatment with remifentanil and H2O2. Cell viability and apoptotic cell death were determined via MTT assay and Hoechst staining, respectively. Mineralized matrix formation was visualized using alizarin red S staining. Western blot analysis was used to determine the expression levels of bone-related genes. Results: Cell viability and mineralized matrix formation increased on remifentanil pretreatment before exposure to H2O2-induced oxidative stress. As determined via western blot analysis, remifentanil pretreatment increased the expression of bone-related genes (Col I, BMP-2, osterix, and TGF-β). However , pretreatment with 3-MA before exposure to remifentanil and H2O2 inhibited remifentanil's protective effects on hFOB cells during oxidative stress. Conclusions: We showed that remifentanil prevents oxidative damage in hFOB cells via a mechanism that may be highly related to autophagy. Further clinical studies are required to investigate its potential as a therapeutic agent.
INTRODUCTION
The bone is an active tissue that continuously undergoes remodeling through a balance between the resorption and bone formation activities of osteoclasts and osteoblasts [1] . An increase in bone-absorbing osteoclasts over the number of bone-producing osteoblasts escalates an individual's vulnerability to fractures because of the resulting reduced bone quality, osteopenia, or to a greater extent, osteoporosis [2, 3] . Polzer et al. have reported that chronic inflammation is a major risk factor for systemic bone loss leading to osteoporotic fracture. Oxidative stress is frequently associated with such chronic inflammation [4] . In a recent study, administration of a lipopolysaccharide, known as endotoxin, decreased femur mineral content and density in a rat model [5] . Another study affirmed that oxidative stress decreases the quality and quantity of osteoblasts and increases the apoptosis of osteoblasts and osteocytes, further confirming the effect of oxidative stress on increasing bone loss [6, 7] .
Bone injury occurs in diverse clinical situations such fracture, orthopedic surgery, plastic gnathoplasty, back surgery, and amputation. During surgery, bone damage and ischemia/reperfusion (I/R) injury often occur and oxygen free radicals are generated. It has been reported that osteoblast-like cells produce considerable amounts of superoxide and hydrogen peroxide (H 2 O 2 ) during the I/R period [8] . Reactive oxygen species (ROS), including superoxide and H 2 O 2 , lead to molecular alteration of cellular components through oxidation of DNA strands, protein cross-links, and side-chains. Consequently, cell morphology, viability, and function may be modified. ROS production is counteracted by an antioxidant defense system including the enzyme scavengers, catalase and glutathione peroxidase [9] . Excessive production of ROS, or a malfunction of the normal cellular redox system, induces oxidative stress, causing cell dysfunction and death [10] .
Autophagy has been reported to play an important role in cellular homeostasis by facilitating the survival or death of cells during physiological and pathological conditions [11] . During a state of oxidative stress, autophagy is known to decrease the concentration of ROS and the prevalence of oxidative injuries in order for the cells to maintain energy levels and to continue producing molecules required for cellular survival [12] . However, increased production of ROS shifts their role from inducers of autophagy to a signal for the initiation of mitophagy, a process whereby the mitochondria is removed. This inhibits the anti-oxidative effect of autophagy, and as a result, cell death is accelerated [13] [14] [15] . On the basis of these reports, we hypothesized that autophagy may be a significant protective factor against oxidative stress.
Remifentanil is an ultra-short acting synthetic μ-opioid receptor agonist, with very rapid onset and offset times owing to its rapid degeneration by nonspecific esterases in the plasma and organs. Owing to these pharmacological properties, remifentanil has been widely applied as an adjuvant analgesic during general anesthesia [16] . Remifentanil pretreatment attenuates hepatic I/R injury in rats via inducible nitric oxide synthase (iNOS). This effect is mediated by a decrease in the production of ROS and an attenuation of the inflammatory response through generation of endogenous NO [17] . Similar suppression of inflammatory responses and inhibition of iNOS expression were observed in mouse models of sepsis [18] . Oxidative stress is closely related to I/R injury. Our previous study indicated that remifentanil preconditioning protected osteoblasts from hypoxia-reoxygenation injury [19] . However, the effects of remifentanil on bone tissue during oxidative stress have not been thoroughly studied. The purpose of our study is to determine whether remifentanil has a protective effect against H 2 O 2 -induced oxidative stress in osteoblasts and to examine its influence on factors associated with the proliferation and differentiation of osteoblasts.
MATERIALS AND METHODS

Reagents
Remifentanil and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) were both purchased from Sigma (St. Louis, MO, USA). 3-Methyladenine (3-MA, a class III PI3K inhibitor) was obtained from Calbiochem (La Jolla, CA, USA). Antibodies against type I collagen (Col I), BMP-2, osterix, and TGF-β were purchased from Abcam (Cambridge, UK). GAPDH, mouse anti-rabbit IgG antibody, and rabbit anti-mouse IgG antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). All other chemicals and reagents were purchased from Sigma, unless otherwise specified. 
Cell culture
The human fetal osteoblast cell line (hFOB 1.19) was purchased from ATCC (Rockville, MD, USA). Cells were cultured in Dulbecco's Modified Eagle Medium: Nutrient Mixture F-12 (DMEM/F-12) with 4 mM L-glutamine, 1.5 g/L sodium bicarbonate, 4.5 g/L glucose, and 1.0 mM sodium pyruvate, supplemented with 10% fetal bovine serum (FBS) and 1% penicillin-streptomycin (GIBCO-BRL, Rockville, MD, USA). Cells were incubated at 37°C in a humidified 5% CO 2 -95% air incubator.
Remifentanil treatment
The stock of remifentanil (RPC) (1 ng/ml) was kept frozen at -20°C until use and was then diluted to the appropriate concentration using DMEM/F-12 when needed. Prior to starting the experiment, cells were grown to approximately 75% confluence and divided into four groups. The control group was incubated at 37°C in a humidified atmosphere with 5% CO 2 for 5 h with no RPC treatment. In the H 2 O 2 group, cells were exposed to 200 μM H2O2 for 2 h and then incubated normally, but were not exposed to remifentanil. In the RPC + H 2 O 2 group, cells were pretreated with 1 ng/ml of remifentanil for 2 h and then exposed to 200 μM H2O2 for 2 h. Lastly, in the 3-MA + RPC + H 2 O 2 group, they were first treated with 1 mM of 3-MA and 1 ng/ml of remifentanil for 1 h and 2 h, respectively. The cells were thereafter exposed to 200 μM of H 2 O 2 for 2 h (Fig. 1 ).
hFOB cell viability assay
The cell viability of hFOB cells was determined using an MTT assay. Cells were cultured in 96-well plates ( at an excitatory emission wavelength of 620 nm.
Fluorescence microscopy
Cells were harvested and cytocentrifuged onto a clean glass slide. Cells were stained with 1 μg/ml Hoechst 33342 for 15 min at 37°C in a dark environment and then washed in phosphate-buffered saline (PBS). The slides were mounted using glycerol. The samples were observed and photographed under an epifluorescence microscope (Carl Zeiss, Goettingen, Germany).
Flow cytometry analysis
The cells were seeded in 60-mm dishes at 70% of the released alizarin red was measured at 550 nm using a microplate reader.
Western blot analysis
The cells (1. Immunostaining with secondary antibodies was completed and SuperSignal West Femto substrates (Pierce, Rockford, IL, USA) were used for detection.
Statistical analysis
The data are expressed as mean ± SE. The statistical significance between groups was analyzed using one-way analysis of variance (ANOVA) and a Dunnett's comparison. Probability (P) values less than 0.05 were considered statistically significant.
RESULTS
Viability of hFOB cells was examined following
treatment with remifentanil and H2O2 by measuring MTT reduction. The effects of remifentanil at various concentrations (0, 0.1, 0.5, 1, 2 ng/ml) on cell viability did Fig. 3 . Viability of human fetal osteoblast cells was evaluated in four groups.
In the H2O2 group, cell viability decreased significantly, while it improved in the remifentanil (RPC) + H2O2 group. In the 3-methyladenine + RPC + H2O2 group, cell viability decreased compared to that in the RPC + H2O2 group. *P < 0.05 compared with control group. The rate of apoptotic cell death was also assessed using a fluorescence-activated cell sorter.
not significantly differ ( Fig. 2A) . Pretreatment with 3-MA prior to remifentanil administration had no influence on cell viability (Fig. 2B) . The application of H 2 O 2 to hFOB cells at various concentrations (0, 25, 50, 100, 200, 400 μM) for 2 h resulted in decreased cell viability at concentrations of 100 μM or higher (Fig. 2C) . Compared to the control group, the H2O2 group showed reduced cell viability (P < 0.05), which was improved by remifentanil pretreatment (1 ng/ml). Treatment with 3-MA (1 mM) decreased the viability of hFOB cells significantly (P < 0.05; Fig. 3 ).
To assess apoptotic cell death, Hoechst 33342 staining DNA, owing to their highly reactive properties [20] . For example, hydroxyl radicals-a type of ROS-generate oxidative injuries, such as oxidized bases, abasic sites, si ngle-strand breaks, double-strand breaks, and DNAprotein crosslinks, causing direct damage to the DNA backbone [21, 22] . In addition, oxidative stress is responsible for the pathophysiology of the aging process and may play a crucial role in the pathogenesis of atherosclerosis, neurodegenerative disease, cancer, and diabetes [23] . Therefore, the development of therapeutic options to prevent oxidative stress and its consequential damage is crucial.
Osteoporosis is influenced by various factors including nutrition, hormones, cytokines, and aging. Indeed, according to a recent study, ROS may be involved in the pathogenesis of bone loss and are responsible for the development of osteoporosis [7] . It has already been reported that oxidative stress modulates the differentiation and survival of osteoblasts and decreases the overall level of bone formation. In addition, oxidative stress promotes osteoclastogenesis and bone resorption, especially in aged people [24, 25] . With life expectancy generally increasing, the probability of undergoing surgery at some point in one's lifetime is increasing as well [26] . In particular,
fractures following traumatic events such as a fall or slip are common in elderly, osteoporotic patients who then require surgery [27] . During surgery, oxidative stress increases due to I/R injury. Elderly patients are vulnerable to oxidative stress due to a deterioration of antioxidant defenses, leading to a delay in bone healing [28] . Our result is both novel and useful because it is the first study that shows the protective effects of remifentanil against oxidative stress in osteoblasts.
In our study, we observed that remifentanil pretreatment increased the synthesis and expression of bonerelated proteins, such as Col I, BMP-2, osterix, and TGF-β. Col I is the major structural protein in the extracellular matrix of bone, accounting for 90% of bone matrix proteins, and playing a crucial role in osteoblast cell adhesion, proliferation, and differentiation [29] .
Osterix is a transcription factor that regulates important osteoblast genes such as Col I, osteocalcin, and osteopontin [30] . 
